Journal of Substance Abuse Treatment
Volume 34, Issue 2 , Pages 215-223 , March 2008

The effect of methadone maintenance treatment on alcohol consumption: A systematic review

  • Anita Srivastava, M.D., M.Sc., C.C.F.P.

      Affiliations

    • Center for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada M5S 2S1
    • Corresponding Author InformationCorresponding author. Center for Addiction and Mental Health, University of Toronto, 33 Russell Street, Toronto, ON, Canada M5S 2S1.
    • ,
  • Meldon Kahan, M.D., F.R.C.P.

      Affiliations

    • Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada M5S 2S1
    • ,
  • Sue Ross, B.Sc., M.Phil., M.B.A., Ph.D.

      Affiliations

    • Department of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada M5S 2S1

Received 31 July 2006 ,Revised 16 March 2007 ,Accepted 4 April 2007.

References 

  1. Anglin MD, Almog IJ, Fisher DG, Peters KR. Alcohol use by heroin addicts: Evidence for an inverse relationship. A study of methadone maintenance and drug-free treatment samples. American Journal of Drug and Alcohol Abuse. 1989;15:191–207
  2. Backmund M, Schütz CG, Meyer K, Eichenlaub D, Soyka M. Alcohol consumption in heroin users, methadone-substituted and codeine-substituted patients—Frequency and correlates of use. European Addiction Research. 2003;9:45–50
  3. Bickel WK, Marion I, Lowinson JH. The treatment of alcoholic methadone patients: A review. Journal of Substance Abuse Treatment. 1987;4:15–19
  4. Bickel WK, Rizzuto P. The naturalistic oscillating patterns of alcohol consumption in alcoholic methadone patients. Journal of Studies on Alcohol. 1991;52:454–457
  5. Bickel WK, Rizzuto P, Zielony RD, Klobas J, Pangiosonlis P, Mernit R, et al. Combined behavioral and pharmacological treatment of alcoholic methadone patients. Journal of Substance Abuse. 1989;1:161–171
  6. Caputo F, Addolorato G, Domenicalli M, Mosti A, Viaggi M, Trevisani F, et al. Short-term methadone administration reduces alcohol consumption in non-alcoholic heroin addicts. Alcohol. 2002;37:164–168
  7. Chetwynd J, Brunton C, Blank M, Plumridge E, Baldwin D. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme. New Zealand Medical Journal. 1995;108:364–366
  8. Cohen M, Korts D, Hanbury R, Sturiano V, Jackson G, Stimmel B. The effect of alcoholism in methadone-maintained persons on productive activity: A randomized control trial. Alcoholism, Clinical and Experimental Research. 1982;6:358–361
  9. Cullen W, Bury G, Barry J, O'Kelly F. Hepatitis C (HCV) infection among drug users attending general practice. Irish Journal of Medical Science. 2003;172:123–127
  10. D'Aunno T, Vaughn TE. Variations in methadone treatment practices. Results from a national study. Journal of the American Medical Association. 1992;267:253–258
  11. Dole VP. Methadone treatment and the acquired immunodeficiency syndrome epidemic. Journal of the American Medical Association. 1989;262:1681–1682
  12. Fairbank JA, Dunteman GH, Condelli WS. Do methadone patients substitute other drugs for heroin? Predicting substance use at 1-year follow-up. American Journal of Drug and Alcohol Abuse. 1993;19:465–474
  13. Farrell M, Ward J, Mattick R, Hall W, Stimson GV, Jarlais D, et al. Methadone maintenance treatment in opiate dependence: A review. British Medical Journal. 1994;309:997–1001
  14. Feng X. Hepatitis C infection: A review. Lippincott's Primary Care Practice. 1999;3:345–353
  15. Gelb AM, Richman BL, Anand OP. Quantitative and temporal relationships of alcohol use in narcotic addicts and methadone maintenance patients undergoing alcohol detoxification. American Journal of Drug and Alcohol Abuse. 1978;5:191–198
  16. Gossop M, Marsden J, Stewart D, Rolfe A. Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study. Drug and Alcohol Dependence. 2000;60:275–286
  17. Gossop M, Stewart D, Browne N, Marsden J. Methadone treatment for opiate dependent patients in general practice and specialist clinic settings: Outcomes at 2-year follow-up. Journal of Substance Abuse Treatment. 2003;24:313–321
  18. Green J, Jaffe J, Carlisi JA, Zaks A. Alcohol use in the opiate use cycle of the heroin addict. International Journal of the Addictions. 1978;13:1021–1033
  19. Green J, Jaffe JH. Alcohol and opiate dependence; a review. Journal of Studies on Alcohol. 1977;38:1274–1293
  20. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology. 1997;129:99–111
  21. Hunt DE, Strug DL, Goldsmith DS, Lipton DS, Robertson K, Truitt L. Alcohol use and abuse: Heavy drinking among methadone clients. American Journal of Drug and Alcohol Abuse. 1986;12:147–164
  22. Jackson G, Korts D, Hanbury R, Sturiano V, Wolpert L, Cohen M, et al. Alcohol consumption in persons on methadone maintenance therapy. American Journal of Drug and Alcohol Abuse. 1982;9:69–76
  23. Johnson BA. An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence. Expert Opinion on Pharmacotherapy. 2004;5:1943–1955
  24. Johnson BA. Progress in the development of topiramate for treating alcohol dependence: From a hypothesis to a proof-of-concept study. Alcoholism: Clinical and Experimental Research. 2004;28:1137–1144
  25. Joseph H, Appel P. Alcoholism and methadone treatment: Consequences for the patient and program. American Journal of Drug and Alcohol Abuse. 1985;11:37–53
  26. Kreek MJ. Opioid interactions with alcohol. Advances in Alcohol & Substance Abuse. 1984;3:35–46
  27. Mann K. Pharmacotherapy of alcohol dependence: A review of the clinical data. CNS Drugs. 2004;18:485–504
  28. Mann K, Lehert P, Morgan MY. The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: Results of a meta-analysis. Alcoholism: Clinical and Experimental Research. 2004;28:51–63
  29. Marcovici M, McLellan T, O'Brien C, Rosenzweig J. Risk for alcoholism and methadone treatment. A longitudinal study. Journal of Nervous and Mental Disease. 1980;168:556–558
  30. McCarthy JJ, Flynn N. Hepatitis C in methadone maintenance patients: Prevalence and public policy implications. Journal of Addictive Diseases. 2001;20:19–31
  31. McCusker M. Influence of hepatitis C status on alcohol consumption in opiate users in treatment. Addiction. 2001;96:1007–1014
  32. Novick DM. The impact of hepatitis C virus infection on methadone maintenance treatment. Mount Sinai Journal of Medicine. 2000;67:437–443
  33. O'Malley SS, Jaffe J, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Archives of General Psychiatry. 1992;49:881–887
  34. Ottomanelli G. Methadone patients and alcohol abuse. Journal of Substance Abuse Treatment. 1999;16:113–121
  35. Rittmannsberger H, Silberbauer CH, Lehner R, Ruschak M. Alcohol consumption during methadone maintenance treatment. European Addiction Research. 2000;6:2–7
  36. Rounsaville BJ, Weissman MM, Kleber HD. The significance of alcoholism in treated opiate addicts. Journal of Nervous and Mental Disease. 1982;170:479–488
  37. Rowan-Szal GA, Chatham LR, Simpson DD. Importance of identifying cocaine and alcohol dependent methadone clients. American Journal on Addictions. 2000;9:38–50
  38. Schiff ER. Hepatitis C and alcohol. Hepatology. 1997;26:39S–42S
  39. Schottenfeld RS, Pakes JR, Kosten TR. Prognostic factors in buprenorphine- versus methadone-maintained patients. Journal of Nervous and Mental Disease. 1998;186:35–43
  40. Schut J, File K, Wohlmuth T. Alcohol use by narcotic addicts in methadone maintenance treatment. Quarterly Journal of Studies on Alcohol. 1973;34:1356–1359
  41. Segest E, Mygind O, Bay H. The influence of prolonged stable methadone maintenance treatment on mortality and employment: An 8-year follow-up. International Journal of the Addictions. 1990;25:53–63
  42. Selvey LA, Denton M, Plant AJ. Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: Factors influencing hepatitis C serostatus. Australian and New Zealand Journal of Public Health. 1997;21:102–104
  43. In:  Simpson DD,  Sells SB editor. Opioid addiction and treatment: A 12-year follow-up. Malobar, FL: Robert E. Krieger Publishing; 1990;p. 57
  44. Stastny D, Potter M. Alcohol abuse by patients undergoing methadone treatment programmes. British Journal of Addiction. 1991;86:307–310
  45. Stimmel B, Hanbury R, Sturiano V, Korts D, Jackson G, Cohen M. Alcoholism as a risk factor in methadone maintenance. A randomized controlled trial. American Journal of Medicine. 1982;73:631–636
  46. Stimmel B, Vernace S, Tobias H. Hepatic dysfunction in heroin addicts. The role of alcohol. Journal of the American Medical Association. 1972;222:811–812
  47. Strain EC, Stitzer M, Liebson I, Bigelow G. Buprenorphine versus methadone in the treatment of opioid dependence: Self-reports, urinalysis, and Addiction Severity Index. Journal of Clinical Psychopharmacology. 1996;16:58–67
  48. Strang J, Marsden J, Cummins M, Farrell M, Finch E, Gossop M, et al. Randomized trial of supervised injectable versus oral methadone maintenance: Report of feasibility and 6-month outcome. Addiction. 2000;95:1631–1645
  49. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry. 1992;49:876–880

PII: S0740-5472(07)00105-5

doi: 10.1016/j.jsat.2007.04.001

Journal of Substance Abuse Treatment
Volume 34, Issue 2 , Pages 215-223 , March 2008

Article Tools